New Alzheimer’s drug should not be rolled out on NHS, says spending watchdog
Nice said the benefits of lecanemab in slowing the condition are ‘just too small to justify the significant cost’.
Published
Last updated
Sorry, we are not accepting comments on this article.
Similar stories
Most popular
- 1
"We're going to attack, we're going to be positive..." Tony Mowbray's style vow on West Brom return Sport|1 hour ago - 2
We look at the best places across the Black Country to get your chippy fix PlusNews|Jan 17 - 3
Chelsea coach discusses 'disaster' ahead of Wolves clash Sport|1 hour ago - 4
''Still makes me proud': Tony Mowbray on first West Brom spell as he makes sensational Albion return Sport|2 hours ago - 5
Emotional appointment as West Brom hero Tony Mowbray makes return 16 years on Sport|11 hours ago